ct

Patent Pick: Conjugated, Penetrating Botulinum Toxin

December 7, 2015 | Contact Author | By: Rachel Grabenhofer, Cosmetics & Toiletries
Close
Fill out my online form.
  • Article
  • Keywords/Abstract
Eye cream dots beneath 850

Keywords: peptide | botulinum toxin | transdermal delivery

Abstract: Patent Picks are chosen by the editors from publicly available sources. Today's patent relates to a cell-penetrating peptide fused to a botulinum toxin recombinant protein, for cosmetic and other purposes.

Patent Picks are chosen by the editors from publicly available sources. Today's patent relates to a cell-penetrating peptide fused to a botulinum toxin recombinant protein.

Cell-penetrating peptide and botulinum toxin conjugate
WIPO Patent Application WO/2015/183044
Publication date: Dec. 3, 2015
Assignee: Procell Therapeutics Inc. and ATGC Co., Ltd.

This invention describes a cell-penetrating peptide fused to a botulinum toxin recombinant protein. Further described is a composition enabling the transdermal delivery of said botulinum toxin recombinant protein for various local treatments of the skin.

The topical delivery of this composition provides the intrinsic effect of botulinum toxin with greater convenience of use, and can be effectively applied for the treatment of various diseases and aesthetic and/or cosmetic purposes.